Phase I study with pegylated human IL-10 (AM0010) alone or in combination with anti-PD-1 or FOLFOX-immune biomarker update Meeting Abstract


Authors: Naing, A.; Infante, J. R.; Hecht, J. R.; Papadopoulos, K. P.; Wong, D. J. L.; Autio, K. A.; Falchook, G. S.; Patel, M. R.; Ott, P. A.; Patnaik, A.; Bendell, J. C.; Van Vlasselaer, P.; Hong, D. S.; Tannir, N. M.; Oft, M.
Abstract Title: Phase I study with pegylated human IL-10 (AM0010) alone or in combination with anti-PD-1 or FOLFOX-immune biomarker update
Meeting Title: 2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 7 Suppl.
Meeting Dates: 2017 Feb 23-25
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-03-01
Language: English
ACCESSION: WOS:000443282900156
PROVIDER: wos
DOI: 10.1200/JCO.2017.35.7_suppl.157
Notes: Meeting Abstract: 157 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Anne Autio
    119 Autio